Your browser doesn't support javascript.
Sodium-Glucose Cotransporter 2 Inhibitors and Major COVID-19 Outcomes: Promising Mechanisms, Conflicting Data, and Intriguing Clinical Decisions.
Patoulias, Dimitrios; Papadopoulos, Christodoulos; Katsimardou, Alexandra; Toumpourleka, Maria; Doumas, Michael.
  • Patoulias D; Second Propedeutic Department of Internal Medicine, General Hospital "Hippokration", Aristotle University of Thessaloniki, Thessaloniki, Greece. dipatoulias@gmail.com.
  • Papadopoulos C; Third Department of Cardiology, General Hospital "Hippokration", Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Katsimardou A; Second Propedeutic Department of Internal Medicine, General Hospital "Hippokration", Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Toumpourleka M; Third Department of Cardiology, General Hospital "Hippokration", Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Doumas M; Second Propedeutic Department of Internal Medicine, General Hospital "Hippokration", Aristotle University of Thessaloniki, Thessaloniki, Greece.
Diabetes Ther ; 11(12): 3003-3005, 2020 Dec.
Article in English | MEDLINE | ID: covidwho-871577

Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study Language: English Journal: Diabetes Ther Year: 2020 Document Type: Article Affiliation country: S13300-020-00942-7

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study Language: English Journal: Diabetes Ther Year: 2020 Document Type: Article Affiliation country: S13300-020-00942-7